Our Founder

Ravi Krishna Vallakati, Ph.D.
Founder & Director
  • Degrees Master of Science (MS) from the University of Minnesota

    Doctorate of Philosophy (PhD) from the University of Houston in Organic Chemistry
  • Experience 20 years of Experience in both Academic Research and Industry
  • Professional Experience He has professional experience at Dr. Reddy’s Laboratories (Hyderabad, India), MD Anderson Cancer Center (Houston, USA), Albany Molecular Research Inc (Albany, USA) and Sciegen Pharmaceuticals (New York, USA).

    Postdoctoral Researcher at The University of Kansas, Lawrence (USA)
  • Research During his MS degree his research focus was on new chiral Hypervalent Iodine reagents. During his PhD, he developed a biomimetic synthesis of all the antimalarial Flindersia alkaloids, delineated a strategy for the enantioselective synthesis of the flinderoles, and explored synthetic methodology for asymmetric conjugate additions. For the duration of his postdoctoral training at the University of Kansas (Lawrence, USA), he worked on Medicinal Chemistry projects and developed synthetic methodology in Fluorine chemistry.
  • Selected Publications

    1. Vallakati, R.;Plotnikov, A.; Altman, R. A. Tetrahedron 2018, 75, 2261–2264 “Synthesis of 2-D-L-Tryptophan by Sequential Ir-Catalyzed Reactions”.

    2. Vallakati, R.; Smuts, J.  P.; Armstrong, D. W.; May, J. A. Tetrahedron Lett. 2013, 54(44), 5892–5894. “On the Biosynthesis and Optical activity of Flinderoles.”

    3. Vallakati, R.; May, J. A. "Biomimetic Synthesis of the antimalarial Flindersial Alkaloids"    J. Am. Chem. Soc. 2012, 134, 6936–6939. 

          (Highlighted in Nature Chemistry: Nat. Chem. 2012, 4, 430)

    4. May, J. A.; Vallakati, R. PCT Int. Appl. 2013, WO 2013109866 A1 20130725. “Preparation of Flindersial alkaloids, derivatives and analogues.”

    5. Zhao, C.; Mitchell, A. T.; Vallakati, R.; Perez, L. M.; Romo, D. J. Am. Chem.Soc. 2012, 134, 3084−3094. “Mechanistic Investigations of the ZnCl2-Mediated Tandem Mukaiyama Lactonization: Evidence for Asynchronous, Concerted Transition State and Discovery of 2-Oxopyridyl Ketene Acetal Variants.” 

    6. Duffy, R. J.; Morris, K. A.; Vallakati, R.; Zhang, W, Romo, D. J. Org. Chem. 2009, 74, 4772–4781. “Asymmetric Synthesis, Structure, and Reactivity of Unexpectedly Stable Spiroepoxy-β-Lactones Including Facile Conversion to Tetronic Acids: Application to (+)-Maculalactone-A.